Labs / Assays & in vitro testing
MYCENAX
Zhubei, Taiwan · mycenax.com
GMP
MYCENAX is a CDMO that provides biopharmaceutical development and manufacturing services for biologics and biosimilars. It serves customers in Taiwan, Japan, Korea, Singapore, Europe, the United States, and other Asia-Pacific regions from sites in Taiwan.
They take quote requests by email.
What they offer
Manufacturability
Assesses product developability to support early biopharmaceutical development.
Cell Line Development
Develops cell lines for biologics production.
Upstream Process Development
Develops upstream manufacturing processes for biologics.
Downstream Process Development
Develops downstream purification processes for biologics.
Analytical Method Development
Develops and validates analytical methods for biopharmaceuticals.
Formulation Development
Develops formulations for biopharmaceutical products.
Technology Transfer
Transfers processes from development to manufacturing or between sites.
Drug Substance Manufacturing
Manufactures drug substance by mammalian cell culture and microbial culture processes.
Aseptic Fill Finish
Provides aseptic filling services for liquid and lyophilized drug products.
Process Characterization (PC) and Process Validation (PV)
Performs process characterization and validation support.
Cell-based Assays
Runs cell-based assays for quality and characterization work.
Characterization Services
Provides physicochemical and biological product characterization services.
What they work on
- Modalities
- Antibody, Bispecific, ADC, mRNA, Cell therapy, Recombinant protein, Biosimilar, Plasmid DNA
- Species and models
- mammalian, microbial, γδT, NK, PBNK, CBNK, K562
- Assays and studies
- LC-MS, LC-MS/MS, SEC-MALS, SV-AUC, DSC, dynamic light scattering, circular dichroism, FT-IR spectroscopy, HILIC-UPLC, RP-HPLC, SPR, ELISA, and 3 more
- Instruments and platforms
- SoloVPE, Maurice systems, Biacore, LC-MS, SEC-MALS, SV-AUC, DSC, DLS
- Scale and capacity
- 25 L to 2,000 L, 5 L to 2,000 L, 2 GMP-compliant facilities, 2 filling lines, 2R, 4R, and 10R vials, liquid prefilled syringes (PFS) and cartridges, Ambr250®, 2 L, 10 L, 50 L, 200 L, G-Rex, and 3 more
- Therapeutic areas
- biopharmaceuticals, biosimilars, cell and gene therapy
- Turnaround
- 3 weeks · 7 months
- What to send
- 250 mL peripheral blood · one leukopak · one cord blood unit
- Type
- CDMO
- Sites
- Zhubei City, Hsinchu County, Taiwan · Zhunan, Miaoli, Taiwan · Taipei City, Taiwan
- Quality
- PIC/S GMP (facilities and manufacturing) · ICH (cell banks and manufacturing requirements) · EMA (facility inspections) · FDA (facility implementation guidance) · PMDA (facility inspections) · Health Canada (facility inspections) · MHRA (facility inspections) · MFDS (facility inspections)
- Serves
- Taiwan, Japan, Korea, Singapore, Asia-Pacific, Europe, United States
- Address
- 3 Road, Zhunan, Miaoli 350401, Taiwan GMP Plant 2 No. 8, Kexi 1st Rd., Zhuna
- Founded
- 2019
Similar labs. GlycoNex, Inc., Intellective Bio, Biofidus GmbH, Evotec
Found in a contract services directory. Listing built from mycenax.com. Work here? Claim this listing.